Take ownership of territory strategy and lead relationships within the healthcare community to launch innovative in vivo CRISPR gene editing therapy for hereditary angioedema. Drive education, stakeholder engagement, and sales excellence in this dynamic market.

Join a team that's pioneering the commercial launch of groundbreaking gene editing therapies. Your expertise will drive strategy, build relationships, and educate healthcare professionals, shaping the future of rare disease treatment.

Join a team that's pioneering the commercial launch of an innovative CRISPR therapy. Drive impactful relationships with healthcare providers while navigating a competitive landscape to transform treatment for hereditary angioedema patients.

Unlock opportunities by leading the launch of a pioneering CRISPR therapy. Engage healthcare providers, build key relationships, and communicate complex scientific concepts to transform the landscape for hereditary angioedema treatment.

Unlock potential by leading the commercial launch of groundbreaking in vivo CRISPR therapy. Drive market penetration through strategic territory management, stakeholder engagement, and scientific communication in the rare disease landscape.